STAT+: Vertex acquires Crinetics Pharmaceuticals for $10 billion as biotech M&A booms

Vertex Pharmaceuticals will spend $10 billion to acquire Crinetics Pharmaceuticals and its drug for a rare endocrine disorder, the companies announced.
💡 AI analysis provides alternative perspectives on current events